Cargando…

IL-26 in the Lung and Its Role in COPD Inflammation

IL-26 is a cytokine expressed by infiltrating pro-inflammatory IL-17-producing T cells in the tissues of patients with chronic lung inflammation. IL-26 induces the chemotactic response of human neutrophils to bacteria and other inflammatory stimuli. In recent years, the innovative properties of IL-2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bartziokas, Konstantinos, Fouka, Evangelia, Loukides, Stelios, Steiropoulos, Paschalis, Bakakos, Petros, Papaioannou, Andriana I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605572/ https://www.ncbi.nlm.nih.gov/pubmed/36294822 http://dx.doi.org/10.3390/jpm12101685

Ejemplares similares

Cardiovascular Diseases in COPD: From Diagnosis and Prevalence to Therapy
por: Papaporfyriou, Anastasia, et al.
Publicado: (2023)

Patient-Reported Outcome Measurements in Patients with COPD-Obstructive Sleep Apnea Overlap Syndrome: Time for Action?
por: Papaioannou, Andriana I, et al.
Publicado: (2022)

Asthma-COPD Overlap Syndrome: Recent Insights and Unanswered Questions
por: Fouka, Evangelia, et al.
Publicado: (2022)

Dual Bronchodilator in the Era of Triple Therapy
por: Papaioannou, Andriana I, et al.
Publicado: (2020)

Identification of asthma phenotypes using blood cell count
por: Papaioannou, Andriana I, et al.
Publicado: (2022)

Eosinopenia as a Prognostic Biomarker for Noninvasive Ventilation Use in COPD Exacerbations
por: Bartziokas, Konstantinos, et al.
Publicado: (2023)

Exhaled breath condensate pH as a biomarker of COPD severity in ex-smokers
por: Papaioannou, Andriana I, et al.
Publicado: (2011)

An algorithmic approach for the treatment of severe uncontrolled asthma
por: Zervas, Eleftherios, et al.
Publicado: (2018)

Sputum interleukin (IL)-13 as a biomarker for the evaluation of asthma control
por: Tsilogianni, Zoi, et al.
Publicado: (2015)

Exploring Mechanisms in COPD: Time for Biomarker Reappraisal?
por: Voulgareli, Ilektra, et al.
Publicado: (2023)

Revisiting IL-13 blockade: can we reach the wonderland the inhaled way?
por: Papaioannou, Andriana I., et al.
Publicado: (2018)

Greek Guidelines for the Management of COPD, a Proposal of a Holistic Approach Based on the needs of the Greek Community
por: Tzanakis, Nikolaos, et al.
Publicado: (2022)

Reducing Tolerance for SABA and OCS towards the Extreme Ends of Asthma Severity
por: Bakakos, Petros, et al.
Publicado: (2022)

Severe asthma: anti-IgE or anti-IL-5?
por: Papathanassiou, Evgenia, et al.
Publicado: (2016)

Sestrin 2 levels are associated with emphysematous phenotype of COPD
por: Angelakis, Leonidas, et al.
Publicado: (2022)

Severe Eosinophilic Asthma
por: Bakakos, Agamemnon, et al.
Publicado: (2019)

Severe Asthma in the Era of Biologics: Continuous Challenges
por: Schoini, Pinelopi, et al.
Publicado: (2023)

SARS-Cov-2 Infection in Severe Asthma Patients Treated With Biologics
por: Papaioannou, Andriana I., et al.
Publicado: (2022)

Primary care and COVID-19: cutting the Gordian knot – the Greek experience and algorithm
por: Tomos, Ioannis, et al.
Publicado: (2020)

Decreased Serum Sirtuin-1 in COPD
por: Yanagisawa, Satoru, et al.
Publicado: (2017)

Recent insights in the role of biomarkers in severe asthma management
por: Fouka, Evangelia, et al.
Publicado: (2022)

Evaluation of the Clinical Effectiveness of the Salmeterol/Fluticasone Fixed-Dose Combination Delivered via the Elpenhaler(®) Device in Greek Patients with Chronic Obstructive Pulmonary Disease and Comorbidities: The AEOLOS Study
por: Steiropoulos, Paschalis, et al.
Publicado: (2021)

Implication of IL-18 in chronic inflammation of severe refractory asthma
por: Rovina, Nikoletta, et al.
Publicado: (2015)

COVID-19 Advanced Care
por: Fouka, Evangelia, et al.
Publicado: (2021)

Epidemiology and Immunopathogenesis of Virus Associated Asthma Exacerbations
por: Bakakos, Agamemnon, et al.
Publicado: (2023)

Paucigranulocytic Asthma: Potential Pathogenetic Mechanisms, Clinical Features and Therapeutic Management
por: Papaioannou, Andriana I., et al.
Publicado: (2022)

Increased Red Cell Distribution Width Is Associated With Disease Severity in Hospitalized Adults With SARS-CoV-2 Infection: An Observational Multicentric Study
por: Karampitsakos, Theodoros, et al.
Publicado: (2020)

New developments in the management of COPD: clinical utility of indacaterol 75 μg
por: Steiropoulos, Paschalis, et al.
Publicado: (2013)

Direct and Indirect Costs of Asthma Management in Greece: An Expert Panel Approach
por: Souliotis, Kyriakos, et al.
Publicado: (2017)

Physiological predictors Of peak inspiRatory flow using Observed lung function resultS (POROS): evaluation at discharge among patients hospitalized for a COPD exacerbation
por: Price, David B, et al.
Publicado: (2018)

The Real Impact of Age on Mortality in Critically Ill COVID-19 Patients
por: Bakakos, Agamemnon, et al.
Publicado: (2023)

Is COPD the Determinant Factor for Myocardial Injury and Cardiac Wall Stress in OSA Patients?
por: Voulgaris, Athanasios, et al.
Publicado: (2023)

Treatment Challenges in Severe Eosinophilic Asthma: Differential Response to Anti-IL-5 and Anti-IL-5R Therapy
por: Bakakos, Agamemnon, et al.
Publicado: (2021)

Modified SCOPE (mSCOPE) Score as a Tool to Predict Mortality in COVID-19 Critically Ill Patients
por: Zanelli, Stavroula, et al.
Publicado: (2023)

New insights into the pathophysiology and therapeutic targets of asthma and comorbid chronic rhinosinusitis with or without nasal polyposis
por: Striz, Ilja, et al.
Publicado: (2023)

The Role of the Microbiome in Connective-Tissue-Associated Interstitial Lung Disease and Pulmonary Vasculitis
por: Drakopanagiotakis, Fotios, et al.
Publicado: (2022)

Lung Cancer and Interstitial Lung Diseases: A Systematic Review
por: Archontogeorgis, Kostas, et al.
Publicado: (2012)

Sirtuin 1: Endocan and Sestrin 2 in Different Biological Samples in Patients with Asthma. Does Severity Make the Difference?
por: Tsilogianni, Zoe, et al.
Publicado: (2020)

Biomarkers to Improve Diagnosis and Monitoring of Obstructive Sleep Apnea Syndrome: Current Status and Future Perspectives
por: Archontogeorgis, Konstantinos, et al.
Publicado: (2014)

IL-26 in the induced sputum is associated with the level of systemic inflammation, lung functions and body weight in COPD patients
por: Savchenko, Lesia, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_2h9e529k3e0qk1vmlsgn04gjvd